Biblio

Author Title [ Type

] Year

Filters: Author is Welner, Robert S [Clear All Filters]

Journal Article

Maroni G, Krishnan I, Alfieri R, Maymi VA, Pandell N, Csizmadia E, Zhang J, Weetall M, Branstrom A, Braccini G, et al. Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment. Cancer Res Commun. 2024;4(3):919-937.

Agarwal P, Li H, Choi K, Hueneman K, He J, Welner RS, Starczynowski DT, Bhatia R. TNF-α-induced alterations in stromal progenitors enhance leukemic stem cell growth via CXCR2 signaling. Cell Rep. 2021;36(2):109386.

Takei H, Coelho-Silva JLuiz, Leal CTavares, Rocha AQueiroz Ar, Bianco TMantello, Welner RS, Mishima Y, Kobayashi IS, Mullally A, Lima K, et al. Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms. Cancer Sci. 2021.

Vu T, Datta A, Banister C, Jin L, Yuan G, Samuel T, Bae S, Eltoum I-E, Manne U, Zhang B, et al. STRAP is a Critical Mediator of APC Mutation-Induced Intestinal Tumorigenesis through a Feed-Forward Mechanism. Gastroenterology. 2021.

Vukadin L, Park B, Mohamed M, Li H, Elkholy A, Torrelli-Diljohn A, Kim J-H, Jeong K, Murphy JM, Harvey CA, et al. A mouse model of ZTTK syndrome reveals indispensable SON functions in organ development and hematopoiesis. bioRxiv. 2023.

Vukadin L, Park B, Mohamed M, Li H, Elkholy A, Torrelli-Diljohn A, Kim J-H, Jeong K, Murphy JM, Harvey CA, et al. A mouse model of Zhu-Tokita-Takenouchi-Kim syndrome reveals indispensable SON functions in organ development and hematopoiesis. JCI Insight. 2024.

Anderson NR, Sheth V, Li H, Harris MW, Qiu S, Crossman DK, Kumar H, Agarwal P, Nagasawa T, Paterson AJ, et al. Microenvironmental CXCL12 deletion enhances Flt3-ITD acute myeloid leukemia stem cell response to therapy by reducing p38 MAPK signaling. Leukemia. 2022.

Qiu S, Sheth VS, Yan C, Liu J, Chacko BK, Li H, Crossman DK, Fortmann SD, Aryal S, Rennhack A, et al. Metabolic Adaptation to Tyrosine Kinase Inhibition in Leukemia Stem Cells. Blood. 2023.

Wolock SL, Krishnan I, Tenen DE, Matkins V, Camacho V, Patel S, Agarwal P, Bhatia R, Tenen DG, Klein AM, et al. Mapping Distinct Bone Marrow Niche Populations and Their Differentiation Paths. Cell Rep. 2019;28(2):302-311.e5.

Shah M, Kumar H, Qiu S, Li H, Harris M, He J, Abraham A, Crossman DK, Paterson A, Welner RS, et al. Low c-Kit expression identifies primitive therapy-resistant CML stem cells. JCI Insight. 2022.

de Figueiredo-Pontes LLobo, Adamcova MK, Grusanovic S, Kuzmina M, Lopes IAparecida, Costa AFernandes, Zhang H, Strnad H, Lee S, Moudra A, et al. Improved hematopoietic stem cell transplantation upon inhibition of natural killer cell-derived interferon-gamma. Stem Cell Reports. 2021.